AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11953729
Drug: Insulin pens
RxNorm normalized name: insulin isophane Pen Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pens with standard needles (Control)
Trial: 9832299
Drug: Erythromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (500 mg three times a day for 4 days)
Trial: 9832299
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg once a day for 4 days)
Trial: 2553425
Drug: HPTH 1-38
RxNorm normalized name: (LEU27)-CYCLO(GLU22-LYS26)-HPTH-(1-31)-NH2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPTH 1-38 (all doses)
Trial: 25877963
Drug: efavirenz 400
RxNorm normalized name: efavirenz 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: efavirenz 400 mg
Trial: 23131756
Drug: 400 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg/kg ivermectin
Trial: 31982355
Drug: Follitropin epsilon
RxNorm normalized name: FOLLITROPIN
DrugBank: Follitropin (DB00066)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Follitropin epsilon 75 IU daily
Trial: 31982355
Drug: Follitropin alfa
RxNorm normalized name: Follitropin Alfa
DrugBank: Follitropin (DB00066)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Follitropin alfa 150 IU daily
Trial: 31493887
Drug: Peanut sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peanut sublingual immunotherapy (SLIT) with 2 mg/d peanut protein for up to 5 years
Trial: 26788484
Drug: BTX-A injection
RxNorm normalized name: BTX-A
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: BTX-A injection + EMG biofeedback
Trial: 23338814
Drug: Sublingual isosorbide
RxNorm normalized name: isosorbide dinitrate Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual isosorbide dinitrate, 5 mg (N‐EST)
Trial: 21146572
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g scFOS (control)
Trial: 18271887
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (misoprostol vaginally)
Trial: 18271887
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (vacuum aspiration)
Trial: 12764372
Drug: AIDA protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIDA protocol (consolidation therapy)
Trial: 23469596
Drug: Electro-acupuncture combined
RxNorm normalized name: combinations of electrolytes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electro-acupuncture combined with general intravenous anesthesia (Group D)
Trial: 23469596
Drug: General intravenous
RxNorm normalized name: General intravenous anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General intravenous anesthesia (Group N)
Trial: 20406937
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) treatment after induction
Trial: 20406937
Drug: No G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No G-CSF treatment
Trial: 10215749
Drug: Intravenous L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-arginine (30 g over 30 min)
Trial: 10215749
Drug: Oral L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-arginine (10 g)
Trial: 328526
Drug: R-75 strain
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens Injectable Suspension [Biothrax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-75 strain live, attenuated, serum inhibitor-resistant influenza B vaccine
Trial: 31483963
Drug: Inhaled recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled recombinant human GM-CSF (sargramostim), 125 μg twice daily for 7 days, every other week for 24 weeks
Trial: 31483963
Drug: Inhaled recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled recombinant human GM-CSF (sargramostim)
Trial: 25952547
Drug: Hatha yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hatha yoga intervention (8-week, twice-weekly)
Trial: 19326174
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg diazepam, given orally 1 hour before 18F-FDG injection
Trial: 17595888
Drug: R (current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R (current formulation)
Trial: 8455331
Drug: Cefpodoxime (CPDX-PR)
DrugBank: Cefpodoxime (DB01416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefpodoxime (CPDX-PR) given orally twice a day at 100-200 mg for 5-21 days
Trial: 19885413
Drug: Control implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control implants
Trial: 17320023
Drug: Parathyroid hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parathyroid hormone
Trial: 10567777
Drug: Ceftriaxone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone plus aminoglycoside with filgrastim (once daily for > or =5 days, > or =2 days, and until ANC > or =1.0x10(9)/l for 2 days)
Trial: 10567777
Drug: Out-patient treatment
RxNorm normalized name: Cough Out
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Out-patient treatment (early discharge)
Trial: 7600120
Drug: recombinant hirudin
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant hirudin (HBW 023, 0.35 mg/kg body wt SC)
Trial: 678831
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg oxamniquine
Trial: 678831
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg oxamniquine
Trial: 30649485
Drug: Computed tomography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computed tomography (CT)‐based image‐guided brachytherapy (IGBT) with whole‐pelvic radiotherapy and concurrent chemotherapy (76% of patients)
Trial: 19801228
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine (CHX) gel
Trial: 23172172
Drug: PRT-201 (0.0033
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRT-201 (0.0033 to 9 mg)
Trial: 23172172
Drug: PRT-201 (Low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRT-201 (Low Dose)
Trial: 1977781
Drug: Astemizole, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole, 10 mg
Trial: 11246381
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac
Trial: 15243302
Drug: Intravenous treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous treprostinil sodium
Trial: 1386977
Drug: Ondansetron injection
RxNorm normalized name: ondansetron Injection
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron injection (4 mg once daily by intravenous administration for 3-5 consecutive days)
Trial: 1386977
Drug: Ondansetron injection
RxNorm normalized name: ondansetron Injection
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron injection
Trial: 28267236
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day vonoprazan for 8 weeks
Trial: 24053577
Drug: Auricular acupuncture
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular acupuncture treatment two times per week for 4 weeks
Trial: 12943178
Drug: Auricular acupuncture
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular acupuncture treatment
Trial: 16950986
Drug: Neonatal indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neonatal indomethacin treatment
Trial: 11748505
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aerobic and strength training (P4 and P6)
Trial: 7995681
Drug: GGGS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GGGS treatment
Trial: 28961020
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 250 µg
Trial: 2788406
Drug: Ostoprin (4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ostoprin (4.0 g per day)
Trial: 30666100
Drug: IND/GLY 110/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IND/GLY 110/50 µg once daily
Trial: 28154349
Drug: 2.5 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g/d of ALA‐DAG
Trial: 21814588
Drug: Thiabendazole (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiabendazole (two daily doses of 25 mg/kg for two days)
Trial: 15303645
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment intensity
Trial: 10641044
Drug: Taiga Wurzel
RxNorm normalized name: Saiga tatarica horn extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taiga Wurzel (25 drops three times daily for 30 days)
Trial: 10641044
Drug: Echinacea (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea (40 drops three times daily for 30 days)
Trial: 30639581
Drug: BoNT‐A injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT‐A injection
Trial: 29846607
Drug: Once-daily modified-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily modified-release hydrocortisone
Trial: 29846607
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily glucocorticoid doses
Trial: 8865530
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH, continuous intravenous infusion)
Trial: 2423343
Drug: Verapamil 3
RxNorm normalized name: verapamil 300 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 3 X 80 mg
Trial: 19055813
Drug: FACT (Flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FACT (Flexible Assertive Community Treatment)
Trial: 8617708
Drug: Sertraline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (200 mg/day for 10 days)
Trial: 2729124
Drug: Dilevalol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol 200 mg
Trial: 23643716
Drug: Usual physiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual physiotherapy (1-to-1 advice, manual therapy, and exercise)
Trial: 20336348
Drug: Cilengitide 500
RxNorm normalized name: Cilengitide
DrugBank: Cilengitide (DB11890)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilengitide 500 mg IV twice weekly
Trial: 19246849
Drug: Telmisartan 40
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40 mg and HCTZ 12.5 mg once daily
Trial: 19246849
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg and HCTZ 12.5 mg once daily
Trial: 9497019
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg nicotine patch (Nicotrol)
Trial: 9497019
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg oral cotinine fumarate
Trial: 9497019
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nicotine patch and cotinine
Trial: 7979282
Drug: Ceftriaxone 1
RxNorm normalized name: ceftriaxone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 1 g administered immediately before PE (group I)
Trial: 7979282
Drug: Ceftriaxone 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 3 g administered immediately before PE (group I)
Trial: 7979282
Drug: Ceftriaxone 1
RxNorm normalized name: ceftriaxone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 1 g administered 6 hours before PE (group II)
Trial: 1174085
Drug: Bumetanide 0.25
RxNorm normalized name: bumetanide 0.25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide 0.25 mg
Trial: 27615542
Drug: Nutrition counseling
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition counseling intervention (monthly one-on-one sessions for 12 months)
Trial: 24810891
Drug: Endoluminal venous
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoluminal venous laser therapy (980 nm, continuous mode, 30 W)
Trial: 3361417
Drug: Non-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment control
Trial: 15537171
Drug: 1000mg paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000mg paracetamol (PCM) tablets alone (control)
Trial: 11501511
Drug: Calcitriol 3
RxNorm normalized name: CALCITRIOL 3MCG/GM OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol 3 microg g(‐1) ointment (Silkis ointment)
Trial: 8778950
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg bid)
Trial: 24685559
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy and motivational enhancement therapy with additional check-ups
Trial: 24685559
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy and motivational enhancement therapy without additional check-ups
Trial: 23797469
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg CEE with or without 2.5 mg medroxyprogesterone acetate
Trial: 22350925
Drug: Prolonged-release melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release melatonin (PR-M) 2 mg
Trial: 16809807
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin daily for 2 months
Trial: 16809807
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg simvastatin daily for 2 months
Trial: 8980590
Drug: Ivermectin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (up to 10 doses at 6-month intervals)
Trial: 18458219
Drug: Candesartan (8-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (8-16 mg once daily)
Trial: 16451284
Drug: Short-burst oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-burst oxygen therapy
Trial: 31796225
Drug: A/Slovenia vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A/Slovenia vaccine strain
Trial: 28628269
Drug: Methylphenidate extended-release
RxNorm normalized name: methylphenidate Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate extended-release oral suspension (MEROS) 60 mg under fed conditions
Trial: 28628269
Drug: Methylphenidate extended-release
RxNorm normalized name: methylphenidate Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate extended-release oral suspension (MEROS) 60 mg under fasting conditions
Trial: 16760316
Drug: MCV (Meningococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCV (Meningococcal group C polysaccharide-protein conjugate vaccine)
Trial: 24432673
Drug: Simulated agent
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated agent granules
Trial: 9108848
Drug: Diphtheria-tetanus-pertussis toxoids
RxNorm normalized name: DIPHTHERIA/TETANUS/PERTUSSIS VACCINE INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus-pertussis toxoids vaccine
Trial: 9108848
Drug: Diphtheria-tetanus toxoids
RxNorm normalized name: diphtheria-tetanus toxoids (DT) ped
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus toxoids vaccine
Trial: 6201083
Drug: Dextran infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran infusion
Trial: 25917860
Drug: Subacromial corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial corticosteroid injection
Trial: 14714107
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg every 12 h for 7-21 days
Trial: 14714107
Drug: Vancomycin 1
RxNorm normalized name: vancomycin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin 1 g every 12 h for 7-21 days
Trial: 8243022
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/day for 3 weeks, followed by 10 mg/day for 9 weeks
Trial: 350144
Drug: Tetracycline hydrochloride
RxNorm normalized name: Tetracycline Hydrochloride
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline hydrochloride capsules
Trial: 28290057
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum supplementation (Col), 20 g/day for 14 days
Trial: 23651846
Drug: Nutrient infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nutrient infusion into mid-jejunum
Trial: 21865355
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (AMIO-ON group)
Trial: 21865355
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (AMIO-OFF group)
Trial: 17160982
Drug: Central body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Central body fat distribution and centralized subcutaneous fat (factors 1 and 2)
Trial: 15067098
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics (ciprofloxacin 200 mg and amoxicillin-clavulanate 375 mg every 8 h)
Trial: 11444419
Drug: Lutein (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein (15 mg)
Trial: 11444419
Drug: Lycopene (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene (15 mg)
Trial: 11367649
Drug: Tongmai Jiangzhi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongmai Jiangzhi Oral Liquid (TJOL)
Trial: 3248127
Drug: Dialysate with
RxNorm normalized name: Dialyvite 800 with Zinc Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate with high calcium concentration (1.68 +/- 0.07 mmol/L)
Trial: 29438463
Drug: DHP107 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHP107 (200 mg/m2 orally twice daily days 1, 8, 15 every 4 weeks)
Trial: 29438463
Drug: i.v. paclitaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. paclitaxel (175 mg/m2 day 1 every 3 weeks)
Trial: 7964484
Drug: T cell
RxNorm normalized name: CD4CAR T cells
DrugBank: Anti-CD4 CAR T-cell therapy (DB17281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T cell lines from treatment-responsive Lyme arthritis
Trial: 26659583
Drug: HU alone
RxNorm normalized name: Hu-PHEC Liver
DrugBank: Hu-PHEC Liver (DB18347)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HU alone (HU 500 mg BID)
Trial: 23398960
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral interferon alpha
Trial: 16848808
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A injection (30 IU Botox)
Trial: 16848808
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of botulinum toxin and nitroglycerin
Trial: 10951830
Drug: Verapamil COER-24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil COER-24 180/240 mg (single daily dose at bedtime)
Trial: 8981340
Drug: New matrix
RxNorm normalized name: Matrix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New matrix patch for estradiol delivery (active patch)
Trial: 31580316
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch (control)
Trial: 27578562
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol
Trial: 17976224
Drug: Intravenous nitroglycerine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nitroglycerine
Trial: 31745072
Drug: High-dose eicosapentaenoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose eicosapentaenoic acid (EPA, 1.2g)
Trial: 24621587
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care and a silicone‐adhesive patch (attention control) (n = 16)
Trial: 8847044
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) therapy alone